BRIANNA BOWDREN: Open Payments
NPI 1720762289 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,084 in 96 payments from 18 companies in 2025. Trend: 2023 $1,158 · 2024 $2,947 · 2025 $2,084
Food & beverage: $2,084
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $360 |
| Teva Pharmaceuticals USA, Inc. | 11 | $265 |
| E.R. Squibb & Sons, L.L.C. | 11 | $259 |
| Neurocrine BioSciences, Inc. | 15 | $233 |
| Vanda Pharmaceuticals Inc. | 10 | $216 |
| Alkermes, Inc. | 7 | $145 |
| Otsuka America Pharmaceutical, Inc. | 5 | $109 |
| Lundbeck LLC | 3 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $67 |
| Almatica Pharma LLC | 3 | $66 |
Products named: VRAYLAR, COBENFY, INGREZZA, AUSTEDO XR, HETLIOZ, REXULTI, ARISTADA, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
